Mechanotherapy shows success in healing aged muscles, study finds
By
Ron Rajecki
Mar 23, 2023
The combination of mechanotherapy — the use of mechanical forces to stimulate tissue healing — and anti-inflammatory treatment can help heal damage in aged muscles, according to a new study.
Clinical briefs for Thursday, March 23
By
Ron Rajecki
Mar 23, 2023
Rural nursing home residents reap benefits from mental healthcare through video … NIH: Prior COVID-19 infection dampens response to vaccination … Skirting cholesterol targets raises CV events by 44...
CDC: C. auris spreading at ‘alarming’ rate in U.S. healthcare facilities
By
Alicia Lasek
Mar 22, 2023
Drug-resistant Candida auris, a known threat to nursing homes, has spread rapidly, and a growing number of cases are resistant to first-line treatment, federal researchers report.
Post-op delirium tied to faster cognitive decline in 6-year study
By
Alicia Lasek
Mar 22, 2023
Postoperative delirium may speed the rate of cognitive decline in older adults by 40% within six years after a major elective surgery, a new study has found
Clinical briefs for Wednesday, March 22
By
Alicia Lasek
Mar 22, 2023
AARP: Many older adults still shun vaccines, despite concerns over illnesses … Hydrocortisone use cuts mortality in severe pneumonia, physicians find … About 1 in 3 medical services users don’t see...
Network to develop LTC COVID-19 treatment, infection prevention best practices
By
Kimberly Bonvissuto
Mar 21, 2023
A network of long-term care medical directors and clinicians will develop best practices guidelines for senior living communities, nursing homes and other congregate care settings in Virginia.
Hybrid immunity ups residents’ defense against severe COVID-19, study finds
By
Alicia Lasek
Mar 20, 2023
Nursing home residents infected with COVID-19 prior to vaccination had the strongest protection against severe disease when compared to their peers without such hybrid immunity.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Clinical briefs for Tuesday, March 21
By
Alicia Lasek
Mar 20, 2023
LeadingAge: MA program failures jeopardize health of nearly 30 million older adults … Behavioral health is crucial ingredient in new Michigan home care program … Patients prefer to see test results...
Readmission rates, episode costs higher for patients with dementia
Mar 20, 2023
The cost of 30-day readmission and total 30-day episode costs are higher for patients with Alzheimer disease and related dementias, researchers report.